Venkat R Goskonda

This inventor holds 53 USPTO granted patents and 23 published patent applications, plus 9 CIPO patents and 10 EPO patents, primarily in Cannabinoid Formulations. Top assignees: Hikma Pharmaceuticals USA Inc., Insys Development Company, Inc., Insys Therapeutics, Inc.. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Venkat R Goskonda. Retrieved from https://idiyas.com/inventor/venkat-r-goskonda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 53 (Patent Applications = 23)

% Patents Active = 79.2

CIPO Patents = 9 (Patent Applications = 2)

EPO Patents = 10 (Patent Applications = 19)

Average Co-Inventor Count = 4.5

ph-index = 9

Forward Citations = 306(Granted Patents)

Forward Citations (Not Self Cited) = 204(Dec 10, 2025)

Location History:

Gurnee, IL (US) (2013 - 2014)
Phoenix, AZ (US) (2012 - 2024)

Company Filing History:

17 out of 29

Hikma Pharmaceuticals USA Inc.

patents

17 out of 19

Insys Development Company, Inc.

patents

7 out of 7

Insys Therapeutics, Inc.

patents

4. 3 out of 3

Benuvia Operations, LLC

patents

5. 3 out of 19

Radius Pharmaceuticals, Inc.

Benuvia Therapeutics LLC

Fresh Cut Development, LLC

Years Active: 2012-2026

Loading Chart...

Areas of Expertise:

Cannabinoid Formulations

Epinephrine Spray

Liquid Naloxone

Topical Compositions

Self-Emulsifying

Oral Formulations

Sublingual Spray

Stabilizing Methods

Pain Treatment

Fentanyl Spray

Buprenorphine Formulations

Sildenafil Spray

53 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12544389 - Stable cannabinoid formulations (2026-02-10),

2. 12508221 - Topical compositions and methods of use (2025-12-30),

3. 12496271 - Oral cannabinoid formulations (2025-12-16),

4. 12414915 - Liquid naloxone spray (2025-09-16),

5. 12303599 - Self-emulsifying cannabidiol formulations (2025-05-20),

6. 11975096 - Liquid naloxone spray (2024-05-07),

7. 11911361 - Stable cannabinoid formulations (2024-02-27),

8. 11857678 - Self-emulsifying cannabidiol formulations (2024-01-02),

9. 11771663 - Epinephrine spray formulations (2023-10-03),

10. 11744811 - Methods of stabilizing epinephrine (2023-09-05),

11. 11628139 - Liquid naloxone spray (2023-04-18),

12. 11617713 - Liquid naloxone spray (2023-04-04),

13. 11571384 - Epinephrine spray formulations (2023-02-07),

14. 11517525 - Epinephrine spray formulations (2022-12-06),

15. 11331279 - Stable cannabinoid formulations (2022-05-17),

Title: Spotlight on Inventor Venkat R Goskonda

Introduction:

Venkat R Goskonda, a prolific inventor based in Phoenix, Arizona, has made significant contributions to the world of pharmaceutical formulations through his innovative patents. With 46 patents to his name, Goskonda continues to push the boundaries of science and medicine.

Latest Patents:

Among his latest inventions are stable cannabinoid formulations, which focus on substantially pure cannabidiol and the development of stable cannabinoid pharmaceutical formulations. Additionally, Goskonda's work includes epinephrine spray formulations designed to treat anaphylaxis effectively.

Career Highlights:

Goskonda has a rich professional background, having worked at renowned companies such as Insys Development Company, Inc. and Hikma Pharmaceuticals USA Inc. His expertise and dedication to research and development have led to the successful creation of groundbreaking pharmaceutical products.

Collaborations:

Throughout his career, Venkat R Goskonda has collaborated with esteemed individuals in the field of pharmaceuticals. Notable coworkers include Chandeshwari Chilampalli and Thrimoorthy Potta, who have worked alongside Goskonda to bring his innovative ideas to life.

Conclusion:

Inventor Venkat R Goskonda's passion for innovation and his commitment to improving healthcare through revolutionary patents showcase his invaluable contributions to the industry. His work continues to inspire and drive progress in the field of pharmaceuticals, making him a trailblazer in the realm of inventors.

Profile summary based on public USPTO records.